Compound Report Overview
Compound Name:
SRI-62-834
Compound Identifier:
703008
Mol Structure 2D:
703008
Molecular Weight:
550
Formula:
C29 H60 N O6 P
Development Status:
Clinical Phase IIIII
SMILES:
CCCCCCCCCCCCCCCCCCOCC1(COP(O)(O-)OCCN(C)(C)C)CCCO1